Polo-like kinase 1 is a potential therapeutic target in human melanoma. [electronic resource]
Producer: 20111014Description: 1886-95 p. digitalISSN:- 1523-1747
- Apoptosis -- drug effects
- Cell Cycle Proteins -- genetics
- Cell Line, Tumor
- Cell Survival -- drug effects
- Enzyme Inhibitors -- pharmacology
- Flavonoids -- pharmacology
- G1 Phase -- physiology
- Gene Expression Regulation, Enzymologic -- physiology
- Gene Expression Regulation, Neoplastic -- physiology
- Genomics
- Humans
- MAP Kinase Signaling System -- drug effects
- Melanoma -- genetics
- Nevus, Pigmented -- genetics
- Polymorphism, Single Nucleotide -- genetics
- Protein Serine-Threonine Kinases -- genetics
- Proto-Oncogene Proteins -- genetics
- RNA, Small Interfering -- pharmacology
- Skin Neoplasms -- genetics
- Tumor Suppressor Protein p53 -- metabolism
- Polo-Like Kinase 1
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.